Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine therapies for cancer significantly increase the risk of hair loss.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.